Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67

BACKGROUND: Despite evidence of different malignant potentials, postoperative follow-up assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs) and adjuvant treatment currently is not indicated. This study investigated the role of Ki67 with regard to recurrence and survival af...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Surg Oncol
Asıl Yazarlar: Genç, C. G., Falconi, M., Partelli, S., Muffatti, F., van Eeden, S., Doglioni, C., Klümpen, H. J., van Eijck, C. H. J., Nieveen van Dijkum, E. J. M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2018
Konular:
Pancreatic Tumors
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6028862/
https://ncbi.nlm.nih.gov/pubmed/29789972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-018-6518-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller